Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine for uncomplicated Plasmodium vivax malaria in Thailand
ACTRN12610000554066Phase 4Not yet recruiting
- Sponsor
- Bureau of Vector Borne Diseases
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of chloroquine in malaria, sponsored by Bureau of Vector Borne Diseases. Primary endpoint: WHO-classified treatment outcome. Planned start Aug 2010; status: not yet recruiting.
02
Drugs
chloroquine
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12610000554066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000554066.